1.77
price down icon8.05%   -0.155
after-market After Hours: 1.79 0.02 +1.13%
loading
X 4 Pharmaceuticals Inc stock is traded at $1.77, with a volume of 826.02K. It is down -8.05% in the last 24 hours and down -6.84% over the past month. X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
See More
Previous Close:
$1.925
Open:
$1.9
24h Volume:
826.02K
Relative Volume:
1.09
Market Cap:
$10.25M
Revenue:
-
Net Income/Loss:
$-16.76M
P/E Ratio:
-22.12
EPS:
-0.08
Net Cash Flow:
$-132.97M
1W Performance:
+18.00%
1M Performance:
-6.84%
6M Performance:
-91.09%
1Y Performance:
-92.98%
1-Day Range:
Value
$1.76
$1.95
1-Week Range:
Value
$1.51
$2.25
52-Week Range:
Value
$1.38
$26.83

X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile

Name
Name
X 4 Pharmaceuticals Inc
Name
Phone
857-529-8300
Name
Address
61 NORTH BEACON STREET, BOSTON, MA
Name
Employee
143
Name
Twitter
@x4pharma
Name
Next Earnings Date
2025-03-25
Name
Latest SEC Filings
Name
XFOR's Discussions on Twitter

Compare XFOR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XFOR
X 4 Pharmaceuticals Inc
1.77 13.82M 0 -16.76M -132.97M -0.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.16 120.29B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.58 60.26B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
339.80 43.10B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.89 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.94 33.09B 3.81B -644.79M -669.77M -6.24

X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-12-23 Downgrade B. Riley Securities Buy → Neutral
Aug-30-23 Resumed B. Riley Securities Buy
Dec-22-22 Initiated Cantor Fitzgerald Overweight
Dec-12-22 Initiated Piper Sandler Overweight
Dec-23-19 Initiated Oppenheimer Outperform
Dec-18-19 Initiated ROTH Capital Buy
Dec-09-19 Upgrade Citigroup Neutral → Buy
Dec-05-19 Initiated B. Riley FBR Buy
Jun-07-19 Initiated Stifel Buy
Jun-05-19 Initiated Cowen Outperform
View All

X 4 Pharmaceuticals Inc Stock (XFOR) Latest News

pulisher
01:50 AM

How to integrate X4 Pharmaceuticals Inc. into portfolio analysis toolsEntry Points For Growing Stocks Identified by Models - metal.it

01:50 AM
pulisher
03:26 AM

Strategies to average down on X4 Pharmaceuticals Inc.Sector-Wise Equity Performance Trend Forecast - Newser

03:26 AM
pulisher
03:25 AM

Published on: 2025-07-30 02:25:32 - Newser

03:25 AM
pulisher
03:02 AM

X4 Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Stock Market Strategy Summary - Newser

03:02 AM
pulisher
01:10 AM

How X4 Pharmaceuticals Inc. stock performs during market volatilityFree Access to Real-Time Trade Insights - Newser

01:10 AM
pulisher
Jul 29, 2025

What analysts say about X4 Pharmaceuticals Inc. stock outlookConservative Long Term Growth Plans Under Review - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

X4 Pharmaceuticals Inc. stock daily chart insightsChart Scanner for Swing Trade Timing - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Real time breakdown of X4 Pharmaceuticals Inc. stock performanceFree Daily Smart Money Movement Monitor - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What are analysts’ price targets for X4 Pharmaceuticals Inc. in the next 12 monthsBest Dividend Outlook For Consistent Profits - jammulinksnews.com

Jul 29, 2025
pulisher
Jul 28, 2025

What institutional investors are buying X4 Pharmaceuticals Inc. stockSuperior returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

India Inc Q1 Revenue Growth: 4-6% Estimate - Rediff MoneyWiz

Jul 28, 2025
pulisher
Jul 27, 2025

How does X4 Pharmaceuticals Inc. compare to its industry peersExplosive earnings growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes X4 Pharmaceuticals Inc. stock price move sharplyUnlock expert stock analysis and alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive X4 Pharmaceuticals Inc. stock higher in 2025Unlock expert insights for smarter investing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for X4 Pharmaceuticals Inc.Build wealth steadily with proven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Has X4 Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewFree Stock Tips Group - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why X4 Pharmaceuticals Inc. stock attracts strong analyst attentionFree Exclusive Access to Stock Gurus - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

Why X4 Pharmaceuticals Inc. stock is on top investor watchlistsFree Capital Allocation Plans - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace

Jul 24, 2025
pulisher
Jul 24, 2025

Fierce Biotech Layoff Tracker 2025: Rocket ejects 30% of staffers; Flagship's Tessera and Generate Bio trim teams - Fierce Biotech

Jul 24, 2025
pulisher
Jul 23, 2025

X4 Pharmaceuticals Inc. Stock Analysis and ForecastFree Investment Community - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is X4 Pharmaceuticals Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about X4 Pharmaceuticals Inc. stockSignificant capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives X4 Pharmaceuticals Inc. stock priceUnstoppable profit momentum - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Trump tariffs live updates: Prospects for India, EU deals falter as Trump pushes for higher tariffs - Yahoo Finance

Jul 22, 2025
pulisher
Jul 21, 2025

Bronze Infra (534731) Hits 52 Week HighTremendous growth potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results - The Manila Times

Jul 21, 2025

X 4 Pharmaceuticals Inc Stock (XFOR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.55
price up icon 0.23%
$37.12
price down icon 0.40%
$105.18
price up icon 0.17%
$26.66
price down icon 0.30%
$110.05
price down icon 1.28%
biotechnology ONC
$299.94
price down icon 1.90%
Cap:     |  Volume (24h):